Stockreport

AbCellera and Bruker Reach Global Settlement of Patent Litigation

AbCellera Biologics Inc. - Common Shares  (ABCL) 
PDF VANCOUVER, British Columbia--(BUSINESS WIRE)--AbCellera (Nasdaq: ABCL) today announced that it has entered into a settlement and patent license agreement with Bruker [Read more]